Director, WW Cell Therapy Portfolio, Class Expansion and ST Pipeline

Position Summary Reporting to the Senior Director, the Director, WW Cell Therapy Class Expansion & Solid Tumor (ST) Pipeline serves as a global medical leader responsible for driving CAR‑T class expansion strategy across hematology and autoimmune disease and shaping early‑stage solid tumor pipeline medical strategy. The role drives enterprise‑level strategy, evidence generation, and cross‑functional alignment to accelerate global impact of the cell therapy portfolio. Key Responsibilities Strategic Leadership of Portfolio CAR T Class Expansion: develop and execute global medical strategy for expanding the class of CAR‑T cell therapy across diseases and settings, identify gaps/barriers and implement innovative solutions to improve delivery of transformational cell therapy to patients. Collaborate with cross‑functional partners (Field Medical, WW Medical, Commercial, Clinical, etc.) to leverage synergy, enhance communication, and ensure alignment. Advance evidence generation aligned to CAR T class expansion in partnership with Medical and HEOR matrix. Align WW and market strategies to ensure global execution. Solid Tumor Pipeline Leadership: lead cross‑functional initiatives related to solid tumor pipeline assets, integrating strategies across different therapeutic areas where necessary. Partner with Clinical Development to shape trial strategy and execution, building strong cross‑functional relationships and integrating clinical insights (e.g., site selection, recruitment and enrollment strategy) into a differentiated, evidence‑driven commercialization plan. Collaborate with local medical affairs teams to align disease strategy and tactics, ensuring cohesive action plans. Develop strategic plans for cell therapy entry into solid tumor, including shaping of early asset medical strategies and providing medical input to overall early asset portfolio. Drive cross‑asset collaboration and knowledge sharing, fostering a unified BMS presence in solid tumors, including partnerships across cell therapy and oncology. Serve as subject matter expert to cross‑functional partners across solid tumors to shape development and strategy for early assets, beginning with RCC. Establish and cultivate relationships with thought leaders in the field. Seamless Execution of Core Medical Affairs Deliverables: develop and execute medical plan aligned to overall asset strategy, produce scientific narrative in partnership with cross‑functional matrix, provide strategic input to guide publication planning and execution, serve as key reviewer and feedback provider on abstracts, presentations, and publications as required. Develop and implement congress strategies to achieve impactful presence and engagement, advise on BMS‑sponsored symposia to enhance scientific dialogue. Refine Integrated Evidence Plan (IEP) to ensure alignment with strategic goals, conduct comprehensive reviews of publications and update key launchpad assets, including slide decks, training sessions, and Q&A materials. Lead and support the execution of global advisory boards and strategic committee meetings and assist regional teams with globally impactful advisory initiatives. Provide medical perspective on evidence generation, including expert review and recommendations for new ISR and CRC trials as well as HEOR analyses. Ensure scientific excellence in medical education and effective data exchange, offer medical insights to guide clinical development plans and influence strategic decision‑making processes for both early and late development. Collaborate with global and local market access and marketing teams to align objectives and enhance engagement. Work collaboratively with patient advocacy and professional societies to align objectives and enhance engagement. Qualifications & Experience Advanced Medical/Biology degree (MD, PhD, PharmD) with clinical and/or 6‑8 years of Pharma industry experience required; Medical Affairs or related experience required. Knowledge of CAR‑T therapy preferred, but not required. Familiarity with clinical and translational research activities. Highly organized, efficient, and motivated individual with the ability to lead multiple projects and initiatives across matrix teams. Excellent verbal & written communication skills, including presentations to large groups, senior leadership, facilitation of interactive discussions, and 1:1 discussions with thought leaders. Proven agility in prioritizing and navigating competing demands. Strategic Thinking: Demonstrated strength in understanding overarching company goals, performing strategic assessments, and developing clearly framed choices and recommendations. Proven record of managing complex interactions that drive business strategy & priorities engaging both internal and external stakeholders. Cross‑Functional Experience: Experience working across a range of medical and/or clinical development roles is a plus. Highly collaborative, possess a record of building and maintaining cross‑functional relationships, and able to communicate business topics effectively with senior leadership, peers, and others. Interpersonal Skills: Ability to build relationships, influence, and drive organizational engagement at all levels. Leadership: Ability to lead strategically, drive performance, build alignment, negotiate, and collaborate. Estimated 15‑20% US and global travel; hybrid work model available. Equal Opportunity Statement We are an equal‑opportunity employer and do not discriminate on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, disability status, or any other characteristic protected by law. For more information, visit #J-18808-Ljbffr Bristol-Myers Squibb